Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
10/04/2023 | Huang Jane | President, CMO | Exercise | Restricted Stock Unit | 9.4k | $0.00 | $0 | | 10/04/2023 |
07/04/2023 | Huang Jane | President, CMO | Exercise | Restricted Stock Unit | 9.4k | $0.00 | $0 | | 07/04/2023 |
07/04/2023 | Huang Jane | President, CMO | Payment of Exercise | Common Stock | 3.2k | $4.65 | $15.1k | | 07/04/2023 |
05/25/2023 | Vaddi Krishna | CEO | Purchase | Common Stock | 900 | $5.31 | $4.8k | | 05/24/2023 |
05/24/2023 | Vaddi Krishna | CEO | Purchase | Common Stock | 1000 | $5.01 | $5k | | 05/24/2023 |
05/24/2023 | Lim Bryant David | Chief Legal Officer, Corp Sec. | Purchase | Common Stock | 2.4k | $5.39 | $12.9k | | 05/24/2023 |
05/23/2023 | Chardonnet Laurent | CFO | Purchase | Common Stock | 5k | $5.50 | $27.5k | | 05/23/2023 |
05/23/2023 | Vaddi Krishna | CEO | Purchase | Common Stock | 11.9k | $5.63 | $66.7k | | 05/23/2023 |
05/22/2023 | ORBIMED ADVISORS LLC | 10% Owner | Purchase | Common Stock | 869.6k | $5.75 | $5M | See footnotes | 05/22/2023 |
05/22/2023 | BAKER BROS. ADVISORS LP | 10% Owner | Grant | Prelude Non-Voting Common Stock | 121.2k | $5.75 | $696.8k | See Footnotes | 05/22/2023 |
05/22/2023 | BAKER BROS. ADVISORS LP | 10% Owner | Grant | Prelude Non-Voting Common Stock | 1.3M | $5.75 | $7.6M | See Footnotes | 05/22/2023 |
05/22/2023 | BAKER BROS. ADVISORS LP | 10% Owner | Grant | Warrants to purchase Common Stock | 970.2k | $0.00 | $97 | See Footnotes | 05/22/2023 |
05/22/2023 | BAKER BROS. ADVISORS LP | 10% Owner | Grant | Warrants to purchase Common Stock | 10.6M | $0.00 | $1.1k | See Footnotes | 05/22/2023 |
05/22/2023 | Bonita David P | 10% Owner | Purchase | Common Stock | 869.6k | $5.75 | $5M | See footnotes | 05/22/2023 |
03/01/2023 | Lim Bryant David | Chief Legal Officer, Corp Sec. | Grant | Employee Stock Option (Right to Buy) | 250k | $5.93 | $1.5M | | 03/01/2023 |
02/07/2023 | Huang Jane | President, CMO | Grant | Employee Stock Option (right to buy) | 150k | $7.20 | $1.1M | | 02/07/2023 |
02/07/2023 | Combs Andrew | EVP, Head of Chemistry | Grant | Employee Stock Option (right to buy) | 135k | $7.20 | $972k | | 02/07/2023 |
02/07/2023 | Chardonnet Laurent | CFO | Grant | Employee Stock Option (right to buy) | 135k | $7.20 | $972k | | 02/07/2023 |
02/07/2023 | Vaddi Krishna | CEO | Grant | Employee Stock Option (right to buy) | 330k | $7.20 | $2.4M | | 02/07/2023 |
02/07/2023 | Scherle Peggy | Chief Scientific Officer | Grant | Employee Stock Option (right to buy) | 135k | $7.20 | $972k | | 02/07/2023 |
12/20/2022 | Vaddi Krishna | CEO | Purchase | Common Stock | 19.2k | $5.13 | $98.4k | See Footnote | 12/20/2022 |
06/17/2022 | FRIEDMAN PAUL A | Director | Grant | Director Stock Option (Right to Buy) | 34.3k | $4.74 | $162.6k | | 06/17/2022 |
06/17/2022 | BAKER BROS. ADVISORS LP | 10% Owner | Grant | Non-Qualified Stock Options (right to buy) | 34.3k | $4.74 | $162.6k | See Footnotes | 06/17/2022 |
06/17/2022 | Bonita David P | 10% Owner | Grant | Director Stock Option (Right to Buy) | 34.3k | $4.74 | $162.6k | | 06/17/2022 |
06/17/2022 | Sandor Victor | Director | Grant | Director Stock Option (Right to Buy) | 34.3k | $4.74 | $162.6k | | 06/17/2022 |
06/17/2022 | Babler Martin | Director | Grant | Director Stock Option (Right to Buy) | 31.3k | $4.74 | $148.3k | | 06/17/2022 |
06/17/2022 | Dier Mardi | Director | Grant | Director Stock Option (Right to Buy) | 34.3k | $4.74 | $162.6k | | 06/17/2022 |
06/01/2022 | Chardonnet Laurent | CFO | Purchase | Common Stock | 10k | $4.23 | $42.3k | | 06/01/2022 |
05/02/2022 | Huang Jane | President, CMO | Grant | Employee Stock Option (Right to Buy) | 460k | $4.86 | $2.2M | | 05/02/2022 |
05/02/2022 | Huang Jane | President, CMO | Grant | Restricted Stock Unit | 150k | $0.00 | $0 | | 05/02/2022 |
04/01/2022 | Combs Andrew | EVP, Head of Chemistry | Exercise | Employee Stock Option (right to buy) | 36.1k | $1.89 | $68.2k | | 03/31/2022 |
03/31/2022 | Combs Andrew | EVP, Head of Chemistry | Exercise | Common Stock | 36.1k | $1.89 | $68.2k | | 03/31/2022 |
03/21/2022 | Chardonnet Laurent | CFO | Grant | Common Stock | 6.5k | $7.51 | $48.8k | | 03/21/2022 |
02/15/2022 | Chardonnet Laurent | CFO | Grant | Employee Stock Option (right to buy) | 90k | $10.58 | $952.2k | | 02/15/2022 |
02/15/2022 | Combs Andrew | EVP, Head of Chemistry | Grant | Employee Stock Option (right to buy) | 100k | $10.58 | $1.1M | | 02/15/2022 |
|